nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

11.04.2023 | Original Paper

Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia

verfasst von: Giuliana S. Zuccoli, Juliana M. Nascimento, Pedro M. Moraes-Vieira, Stevens K. Rehen, Daniel Martins-de-Souza

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Schizophrenia is a severe psychiatric disorder of neurodevelopmental origin that affects around 1% of the world’s population. Proteomic studies and other approaches have provided evidence of compromised cellular processes in the disorder, including mitochondrial function. Most of the studies so far have been conducted on postmortem brain tissue from patients, and therefore, do not allow the evaluation of the neurodevelopmental aspect of the disorder. To circumvent that, we studied the mitochondrial and nuclear proteomes of neural stem cells (NSCs) and neurons derived from induced pluripotent stem cells (iPSCs) from schizophrenia patients versus healthy controls to assess possible alterations related to energy metabolism and mitochondrial function during neurodevelopment in the disorder. Our results revealed differentially expressed proteins in pathways related to mitochondrial function, cell cycle control, DNA repair and neuritogenesis and their possible implication in key process of neurodevelopment, such as neuronal differentiation and axonal guidance signaling. Moreover, functional analysis of NSCs revealed alterations in mitochondrial oxygen consumption in schizophrenia-derived cells and a tendency of higher levels of intracellular reactive oxygen species (ROS). Hence, this study shows evidence that alterations in important cellular processes are present during neurodevelopment and could be involved with the establishment of schizophrenia, as well as the phenotypic traits observed in adult patients.

Graphical abstract

Neural stem cells (NSCs) and neurons were derived from induced pluripotent stem cells (iPSCs) from schizophrenia patients and controls. Proteomic analyses were performed on the enriched mitochondrial and nuclear fractions of NSCs and neurons. Whole-cell proteomic analysis was also performed in neurons. Our results revealed alteration in proteins related to mitochondrial function, cell cycle control, among others. We also performed energy pathway analysis and reactive oxygen species (ROS) analysis of NSCs, which revealed alterations in mitochondrial oxygen consumption and a tendency of higher levels of intracellular ROS in schizophrenia-derived cells.

Nur mit Berechtigung zugänglich

Kahn RS, Sommer IE, Murray RM et al (2015) Schizophrenia. Nat Rev Dis Prim. https://doi.org/10.1038/nrdp.2015.67CrossRefPubMed

Insel TR (2010) Rethinking schizophrenia. Nature 468:187–193. https://doi.org/10.1038/nature09552CrossRefPubMed

Martins-de-Souza D, Harris LW, Guest PC, Bahn S (2011) The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid Redox Signal 15:2067–2079. https://doi.org/10.1089/ars.2010.3459CrossRefPubMed

Nascimento JM, Martins-de-Souza D (2015) The proteome of schizophrenia. npj Schizophr 1:14003. https://doi.org/10.1038/npjschz.2014.3CrossRefPubMedPubMedCentral

Zuccoli GS, Saia-Cereda VM, Nascimento JM, Martins-de-Souza D (2017) The energy metabolism dysfunction in psychiatric disorders postmortem brains: Focus on proteomic evidence. Front Neurosci 11:1–14. https://doi.org/10.3389/fnins.2017.00493CrossRef

Taylor SW, Fahy E, Ghosh SS (2003) Global Organellar Proteom 21:82–88

Pedrosa E, Sandler V, Shah A et al (2011) Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J Neurogenet 25:88–103. https://doi.org/10.3109/01677063.2011.597908CrossRefPubMed

Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676. https://doi.org/10.1016/j.cell.2006.07.024CrossRefPubMed

Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872. https://doi.org/10.1016/j.cell.2007.11.019CrossRefPubMed

10.

Marchetto MC, Brennand KJ, Boyer LF, Gage FH (2011) Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises. Hum Mol Genet 20:R109–R115. https://doi.org/10.1093/hmg/ddr336CrossRefPubMedPubMedCentral

11.

Sebastian R, Song Y, Pak CH (2022) Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models. Schizophr Res. https://doi.org/10.1016/j.schres.2022.06.028CrossRefPubMed

12.

Notaras M, Lodhi A, Fang H et al (2021) The proteomic architecture of schizophrenia iPSC-derived cerebral organoids reveals alterations in GWAS and neuronal development factors. Transl Psychiatry 11:1–16. https://doi.org/10.1038/s41398-021-01664-5CrossRef

13.

Notaras M, Lodhi A, Dündar F et al (2022) Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. Mol Psychiatry 27:1416–1434. https://doi.org/10.1038/s41380-021-01316-6CrossRefPubMed

14.

Marchetto MCN, Winner B, Gage FH (2010) Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet 19:R71–R76. https://doi.org/10.1093/hmg/ddq159CrossRefPubMedPubMedCentral

15.

Brennand KJ, Simone A, Jou J et al (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221–225. https://doi.org/10.1038/nature09915CrossRefPubMedPubMedCentral

16.

Brennand KJ, Marchetto MC, Benvenisty N et al (2015) Creating patient-specific neural cells for the in Vitro Study of Brain Disorders. Stem Cell Rep 5:933–945. https://doi.org/10.1016/j.stemcr.2015.10.011CrossRef

17.

Casas BS, Vitória G, Do Costa MN et al (2018) HiPSC-derived neural stem cells from patients with schizophrenia induce an impaired angiogenesis. Transl Psych. https://doi.org/10.1038/s41398-018-0095-9CrossRef

18.

Da Silveira B, De Paulsen R, Maciel M, Galina A et al (2012) Altered Oxygen Metabolism Associated to Neurogenesis of Induced Pluripotent Stem Cells Derived From a Schizophrenic Patient. Cell Transpl 21:1547–1559. https://doi.org/10.3727/096368911X600957CrossRef

19.

da Silveira B, Paulsen SC, Cardoso MP, Stelling, et al (2014) Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells. Schizophr Res 154:30–35. https://doi.org/10.1016/j.schres.2014.02.007CrossRef

20.

Narula K, Datta A, Chakraborty N, Chakraborty S (2013) Comparative analyses of nuclear proteome: extending its function. Front Plant Sci 4:1–14. https://doi.org/10.3389/fpls.2013.00100CrossRef

21.

Khacho M, Slack RS (2018) Mitochondrial dynamics in the regulation of neurogenesis: From development to the adult brain. Dev Dyn 247:47–53. https://doi.org/10.1002/dvdy.24538CrossRefPubMed

22.

Hroudová J, Fišar Z (2011) Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry Clin Neurosci 65:130–141CrossRefPubMed

23.

Rezin GT, Amboni G, Zugno AI et al (2009) Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34:1021–1029. https://doi.org/10.1007/s11064-008-9865-8CrossRefPubMed

24.

Trindade P, Nascimento JM, Casas BS et al (2023) Induced pluripotent stem cell-derived astrocytes from patients with schizophrenia exhibit an inflammatory phenotype that affects vascularization. Mol Psychiatry 28:871–882. https://doi.org/10.1038/s41380-022-01830-1CrossRefPubMed

25.

Sochacki J, Devalle S, Reis M et al (2016) Generation of iPS cell lines from schizophrenia patients using a non-integrative method. Stem Cell Res 17:97–101. https://doi.org/10.1016/j.scr.2016.05.017CrossRefPubMed

26.

Nascimento JM, Saia-Cereda VM, Zuccoli GS et al (2022) Proteomic signatures of schizophrenia-sourced iPSC-derived neural cells and brain organoids are similar to patients’ postmortem brains. Cell Biosci 12:1–16. https://doi.org/10.1186/s13578-022-00928-xCrossRef

27.

Clayton DA, Shadel GS (2014) Isolation of mitochondria from tissue culture cells. Cold Spring Harb Protoc 2014:1109–1111. https://doi.org/10.1101/pdb.prot080002CrossRef

28.

Shevchenko A, Tomas H, Havliš J et al (2007) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1:2856–2860. https://doi.org/10.1038/nprot.2006.468CrossRef

29.

Calvano SE, Xiao W, Richards DR et al (2005) A network-based analysis of systemic inflammation in humans. Nature 437:1032–1037. https://doi.org/10.1038/nature03985CrossRefPubMed

30.

Wu X, Al HM, Chen JY (2014) Pathway and network analysis in proteomics. J Theor Biol 362:44–52. https://doi.org/10.1016/j.jtbi.2014.05.031CrossRefPubMed

31.

Krämer A, Green J, Pollard J, Tugendreich S (2014) Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30:523–530. https://doi.org/10.1093/bioinformatics/btt703CrossRefPubMed

32.

Oparka M, Walczak J, Malinska D et al (2016) Quantifying ROS levels using CM-H2DCFDA and HyPer. Methods 109:3–11. https://doi.org/10.1016/j.ymeth.2016.06.008CrossRefPubMed

33.

Beckervordersandforth R, Ebert B, Schäffner I et al (2017) Role of mitochondrial metabolism in the control of early lineage progression and aging phenotypes in adult hippocampal neurogenesis. Neuron 93:560-573.e6. https://doi.org/10.1016/j.neuron.2016.12.017CrossRefPubMedPubMedCentral

34.

Khacho M, Clark A, Svoboda DS et al (2017) Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis. Hum Mol Genet 26:3327–3341. https://doi.org/10.1093/hmg/ddx217CrossRefPubMedPubMedCentral

35.

Khacho M, Clark A, Svoboda DS et al (2016) Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program. Cell Stem Cell 19:232–247. https://doi.org/10.1016/j.stem.2016.04.015CrossRefPubMed

36.

Steib K, Schaffner I, Jagasia R et al (2014) Mitochondria modify exercise-induced development of stem cell-derived neurons in the adult brain. J Neurosci 34:6624–6633. https://doi.org/10.1523/JNEUROSCI.4972-13.2014CrossRefPubMedPubMedCentral

37.

Candelario KM, Shuttleworth CW, Cunningham LA (2013) Neural stem/progenitor cells display a low requirement for oxidative metabolism independent of hypoxia inducible factor-1alpha expression. J Neurochem 125:420–429. https://doi.org/10.1111/jnc.12204CrossRefPubMedPubMedCentral

38.

Studer L, Csete M, Lee SH et al (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20:7377–7383. https://doi.org/10.1523/jneurosci.20-19-07377.2000CrossRefPubMedPubMedCentral

39.

Pistollato F, Chen HL, Schwartz PH et al (2007) Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 35:424–435. https://doi.org/10.1016/j.mcn.2007.04.003CrossRefPubMed

40.

Panchision DM (2009) The role of oxygen in regulating neural stem cells in development and disease. J Cell Physiol 220:562–568. https://doi.org/10.1002/jcp.21812CrossRefPubMed

41.

Bélanger M, Allaman I, Magistretti PJ (2011) Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab 14:724–738. https://doi.org/10.1016/j.cmet.2011.08.016CrossRefPubMed

42.

Kim D, Rhee I, Paik J (2014) Metabolic circuits in neural stem cells. Cell Mol Life Sci 71:4221–4241. https://doi.org/10.1007/s00018-014-1686-0CrossRefPubMedPubMedCentral

43.

Kann O, Kovács R (2007) Mitochondria and neuronal activity. Am J Physiol Physiol 292:C641–C657. https://doi.org/10.1152/ajpcell.00222.2006CrossRef

44.

Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M (2015) Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications. Neurosci Biobehav Rev 48:10–21. https://doi.org/10.1016/j.neubiorev.2014.11.005CrossRefPubMed

45.

Levy M, Faas GC, Saggau P et al (2003) Mitochondrial regulation of synaptic plasticity in the hippocampus. J Biol Chem 278:17727–17734. https://doi.org/10.1074/jbc.M212878200CrossRefPubMed

46.

Nicholls DG, Budd SL (2000) Mitochondria and Neuronal Survival. Physiol Rev 80:315–360. https://doi.org/10.1152/physrev.2000.80.1.315CrossRefPubMed

47.

Ni P, Noh H, Park GH et al (2019) iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function. Mol Psychiatry. https://doi.org/10.1038/s41380-019-0423-3CrossRefPubMedPubMedCentral

48.

Robicsek O, Karry R, Petit I et al (2013) Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 18:1067–1076. https://doi.org/10.1038/mp.2013.67CrossRefPubMed

49.

Cremisi F, Philpott A, Ohnuma SI (2003) Cell cycle and cell fate interactions in neural development. Curr Opin Neurobiol 13:26–33. https://doi.org/10.1016/S0959-4388(03)00005-9CrossRefPubMed

50.

Katsel P, Davis KL, Li C et al (2008) Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology 33:2993–3009. https://doi.org/10.1038/npp.2008.19CrossRefPubMed

51.

Fan Y, Abrahamsen G, McGrath JJ, MacKay-Sim A (2012) Altered cell cycle dynamics in schizophrenia. Biol Psychiatry 71:129–135. https://doi.org/10.1016/j.biopsych.2011.10.004CrossRefPubMed

52.

Raza MU, Tufan T, Wang Y et al (2017) DNA damage in major psychiatric diseases. Neurotox Res 30:251–267. https://doi.org/10.1007/s12640-016-9621-9CrossRef

53.

Odemis S, Tuzun E, Gulec H et al (2016) Association between polymorphisms of DNA repair genes and risk of Schizophrenia. Genet Test Mol Biomark 20:11–17. https://doi.org/10.1089/gtmb.2015.0168CrossRef

54.

Saadat M, Pakyari N, Farrashbandi H (2008) Genetic polymorphism in the DNA repair gene XRCC1 and susceptibility to schizophrenia. Psychiatry Res 157:241–245. https://doi.org/10.1016/j.psychres.2007.07.014CrossRefPubMed

55.

Markkanen E, Meyer U, Dianov GL (2016) Dna damage and repair in schizophrenia and autism: Implications for cancer comorbidity and beyond. Int J Mol Sci. https://doi.org/10.3390/ijms17060856CrossRefPubMedPubMedCentral

56.

Lee Y, McKinnon PJ (2007) Responding to DNA double strand breaks in the nervous system. Neuroscience 145:1365–1374. https://doi.org/10.1016/j.neuroscience.2006.07.026CrossRefPubMed

57.

Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606–619. https://doi.org/10.1038/nrg1879CrossRefPubMed

58.

Woodgett JR, Cohen P (1984) Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthease kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta (BBA)/Protein Struct Mol 788:339–347. https://doi.org/10.1016/0167-4838(84)90047-5CrossRef

59.

Hur EM, Zhou FQ (2010) GSK3 signalling in neural development. Nat Rev Neurosci 11:539–551. https://doi.org/10.1038/nrn2870CrossRefPubMedPubMedCentral

60.

Bijur GN, Jope RS (2003) Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem 87:1427–1435. https://doi.org/10.1046/j.1471-4159.2003.02113.xCrossRefPubMedPubMedCentral

61.

Ong SB, Hall AR, Dongworth RK et al (2015) Akt protects the heart against ischaemia-reperfusion injury by modulating mitochondrial morphology. Thromb Haemost 113:513–521. https://doi.org/10.1160/TH14-07-0592CrossRefPubMed

62.

Wang L, Zhou K, Fu Z et al (2017) Brain development and Akt Signaling: the crossroads of signaling pathway and neurodevelopmental diseases. J Mol Neurosci 61:379–384. https://doi.org/10.1007/s12031-016-0872-yCrossRefPubMed

63.

Emamian ES (2012) AKT/GSK3 signaling pathway and schizophrenia. Front Mol Neurosci 5:1–12. https://doi.org/10.3389/fnmol.2012.00033CrossRef

64.

Polleux F, Snider W (2010) Initiating and growing an axon. Cold Spring Harb Perspect Biol 2:1–19. https://doi.org/10.1101/cshperspect.a001925CrossRef

65.

Da Silva JS, Dotti CG (2002) Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis. Nat Rev Neurosci 3:694–704. https://doi.org/10.1038/nrn918CrossRefPubMed

66.

Bellon A (2007) New genes associated with schizophrenia in neurite formation: A review of cell culture experiments. Mol Psychiatry 12:620–629. https://doi.org/10.1038/sj.mp.4001985CrossRefPubMed

67.

Kamiya A, Kubo KI, Tomoda T et al (2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7:1067–1078. https://doi.org/10.1038/ncb1328CrossRef

68.

Ozeki Y, Tomoda T, Kleiderlein J et al (2003) Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100:289–294. https://doi.org/10.1073/pnas.0136913100CrossRefPubMed

69.

Brennand KJ, Gage FH (2011) Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia. Stem Cells 29:1915–1922. https://doi.org/10.1002/stem.762CrossRefPubMed

70.

Jones LB, Johnson N, Byne W (2002) Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex. Psychiatry Res Neuroimaging 114:137–148CrossRef

71.

Kalus P, Mu CATJ, Zuschratter W, Senitz D (2000) The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. NeuroReport 11:3621–3625CrossRefPubMed

72.

Zheng X, Boyer L, Jin M et al (2016) Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation. Elife 5:1–25. https://doi.org/10.7554/eLife.13374CrossRef

73.

Nugent AA, Kolpak AL, Engle EC (2012) Human disorders of axon guidance. Curr Opin Neurobiol 22:837–843. https://doi.org/10.1016/j.conb.2012.02.006CrossRefPubMedPubMedCentral

74.

Korecka JA, Levy S, Isacson O (2016) In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells. Mol Cell Neurosci 73:3–12. https://doi.org/10.1016/j.mcn.2015.12.004CrossRefPubMed

75.

Gilman SR, Chang J, Xu B et al (2012) Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nat Neurosci 15:1723–1728. https://doi.org/10.1038/nn.3261CrossRefPubMedPubMedCentral

76.

Lewis D, a, Lieberman J a, (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325–334. https://doi.org/10.1016/S0896-6273(00)00111-2CrossRefPubMed

77.

Smith GM, Gallo G (2018) The role of mitochondria in axon development and regeneration. Dev Neurobiol 78:221–237. https://doi.org/10.1002/dneu.22546CrossRefPubMed

78.

Do KQ, Cabungcal JH, Frank A et al (2009) Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19:220–230. https://doi.org/10.1016/j.conb.2009.05.001CrossRefPubMed

79.

Behrens MM, Ali SS, Dugan LL (2008) Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of Schizophrenia. J Neurosci 28:13957–13966. https://doi.org/10.1523/JNEUROSCI.4457-08.2008CrossRefPubMedPubMedCentral

80.

Pedrini M, Massuda R, Fries GR et al (2012) Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res 46:819–824. https://doi.org/10.1016/j.jpsychires.2012.03.019CrossRefPubMed

81.

Wells PG, Mccallum GP, Chen CS et al (2009) Oxidative stress in developmental origins of disease: Teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 108:4–18. https://doi.org/10.1093/toxsci/kfn263CrossRefPubMed

82.

Liu G, Dwyer T (2014) Microtubule dynamics in axon guidance. Neurosci Bull 30:569–583. https://doi.org/10.1007/s12264-014-1444-6CrossRefPubMedPubMedCentral

83.

Pacheco A, Gallo G (2016) Actin filament-microtubule interactions in axon initiation and branching. Brain Res Bull 126:300–310. https://doi.org/10.1016/j.brainresbull.2016.07.013CrossRefPubMedPubMedCentral

84.

Perez-Riverol Y, Csordas A, Bai J et al (2019) The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res 47:D442–D450. https://doi.org/10.1093/nar/gky1106CrossRefPubMed

Titel: Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia
verfasst von: Giuliana S. Zuccoli
Juliana M. Nascimento
Pedro M. Moraes-Vieira
Stevens K. Rehen
Daniel Martins-de-Souza
Publikationsdatum: 11.04.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2023
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-023-01605-x

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia

Abstract

Graphical abstract

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Update Psychiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2023

Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case–control association study

Shared Decision Making Assistant (SDMA) and other digital tools for choosing antipsychotics in schizophrenia treatment

Blood–brain barrier dysfunction and folate and vitamin B12 levels in first-episode schizophrenia-spectrum psychosis: a retrospective chart review

Attentional biases in facial emotion processing in individuals at clinical high risk for psychosis

Reinforcement learning profiles and negative symptoms across chronic and clinical high-risk phases of psychotic illness

Network analysis of discrete emotional states measured via ecological momentary assessment in schizophrenia

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Update Psychiatrie